TomoTherapy Inc. made a big splash today in its debut as a public company.
Even after adding shares and pricing above the previously set range of its initial public offering of stock, the Madison-based maker of cancer treatment systems (and UW-Madison spin-off) opened up about 25 percent as it launched on Nasdaq under the symbol “TTPY.”